Breaking News
April 25, 2018 - Studies provide advanced knowledge about renal cancer
April 25, 2018 - Researchers develop low-cost, portable laboratory on a phone to detect infections
April 25, 2018 - Early treatment improves leg ulcer healing rates
April 25, 2018 - U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations
April 25, 2018 - Redefined Alzheimer’s biology has implications for drug design
April 25, 2018 - BetterYou’s Iron Oral Spray recognized as ‘Best New Health and Nutrition Product’
April 24, 2018 - New imaging technology to effectively screen for colorectal cancer among young adults
April 24, 2018 - UW developmental psychologist wins 2018 Alan T. Waterman Award
April 24, 2018 - Adipose-derived mesenchymal stem cells combined with fibrin matrix influences restoration of motor functions
April 24, 2018 - Exposure to toxin found in sheep may be linked to development of MS
April 24, 2018 - FDA Approves Intravenous Formulation of Akynzeo (fosnetupitant/palonosetron) for Chemotherapy-Induced Nausea and Vomiting
April 24, 2018 - Is Alzheimer’s caused by disruptions to the brain’s energy supply?
April 24, 2018 - Low concentrations of antibiotics can develop high antibiotic resistance in bacteria
April 24, 2018 - Imagined and real movements have similar brain mechanisms, research suggests
April 24, 2018 - Alcoholic drinks affect oral bacteria tied to diseases
April 24, 2018 - Mechanism in Non-Contact ACL Tears Similar in Men, Women
April 24, 2018 - Buprenorphine may be safer than methadone if treatment duration is longer, study suggests
April 24, 2018 - NF-κB1 gene known to drive cancer development is critical for preventing stomach cancers
April 24, 2018 - New tool helps blind, low-vision users navigate modern webpages more easily
April 24, 2018 - Hippo pathway plays essential role in embryonic development of the mouse heart
April 24, 2018 - Vegetarian diet and Mediterranean diet close to each other in health benefits
April 24, 2018 - FSU receives $1.5 million federal grant for innovative suicide prevention research
April 24, 2018 - Health Tip: Screening for Cancer in Older Adults
April 24, 2018 - Investigators highlight potential of exercise in addressing substance abuse in teens
April 24, 2018 - Study shows people might develop dementia later and live with it for a shorter period of time
April 24, 2018 - EMBL scientists develop new illumination method to manage neuropathic pain
April 24, 2018 - New compound could offer pain-relieving properties without risk of addiction
April 24, 2018 - New drug treatment could be promising therapeutic approach for millions with asthma
April 24, 2018 - Study provides guidance on using cannabis for treatment of stress, anxiety, and depression
April 24, 2018 - By Royal approval: Queen’s Award success for Elucigene
April 24, 2018 - The role of ‘extra’ DNA in cancer evolution and therapy resistance
April 24, 2018 - Researchers identify tools that caregivers could use to detect delirium in older adults
April 24, 2018 - What to Look Out For
April 24, 2018 - Drugs prescribed for newborns vary widely between NICUs, study finds
April 24, 2018 - FM4200 pressure-resistant mass flow meter from Sensirion
April 24, 2018 - Study links past experiences with bias and avoidance of doctors in women with higher BMI
April 24, 2018 - Role of extrachromosomal pieces of DNA in cancer development and treatment resistance
April 24, 2018 - Rehabilitation technique for stroke appears beneficial for multiple sclerosis patients
April 24, 2018 - Women who find purpose and meaning in life less likely to have anxiety, study shows
April 24, 2018 - Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse for Treatment of Lambert-Eaton Myasthenic Syndrome
April 24, 2018 - Suicide and homicide rates show large racial disparities across US states
April 24, 2018 - Scientists develop tissue-engineered models to better understand cancer metastases
April 24, 2018 - NuProbe to commercialize Wyss Institute’s new technology to facilitate precision medicine
April 24, 2018 - Special series explores pasteurized donor human milk use for hospitalized infants
April 24, 2018 - Slight changes in patient’s position during radiotherapy may impact survival chances
April 24, 2018 - FDA Approves Tagrisso (osimertinib) as First-Line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer
April 24, 2018 - After knee replacement, play on
April 24, 2018 - Contact precautions do not limit spread of drug-resistant bacteria in ICUs
April 24, 2018 - Researchers discover genetic catalysts that accelerate evolution of antibiotic resistance in bacteria
April 24, 2018 - WPI researcher launches mobile app for assessing perinatal depression in women
April 24, 2018 - Researchers identify superior blood-based biomarker for assessing sports-related concussions
April 24, 2018 - Gene Therapy Found to Be Promising for β-Thalassemia
April 24, 2018 - Bariatric surgery can lead to changes in relationship status
April 24, 2018 - GPs must embrace digital technologies to make healthcare access easier for patients
April 24, 2018 - Novel stem cell therapy may transform current paradigms for treating heart failure patients
April 24, 2018 - Maternal depression during and after pregnancy linked to poorer child neurodevelopment
April 24, 2018 - Vitamin D and magnesium supplements provide right nutritional support to athletes
April 24, 2018 - Could a Tattoo Someday Spot Your Cancer?
April 24, 2018 - Throat reflexes differ in people with tetraplegia and sleep apnea
April 24, 2018 - Study shows no increased risk of breast cancer recurrence after DIEP flap reconstruction
April 24, 2018 - Nearly three-quarters of commonly used medical scopes tainted by bacteria
April 24, 2018 - Home-based treatment program offers robust and sustained relief for IBS patients
April 24, 2018 - New IntelliCyt Cy-Clone PLUS streamlines clone ranking and selection for cell line development
April 24, 2018 - Scientists examine how specific eating patterns could help fight cancer and obesity
April 24, 2018 - Study sheds new light on how bilinguals process language
April 24, 2018 - Probiotics can improve liver health, shows study
April 24, 2018 - Study may explain how chemoresistance evolves over time in some triple-negative breast cancers
April 24, 2018 - Role of midbrain in encoding identity errors
April 23, 2018 - Salamander study provides clues for treating spinal cord injuries
April 23, 2018 - Relaxation after work could give better night’s sleep
April 23, 2018 - Loneliness on its way to becoming Britain’s most lethal condition
April 23, 2018 - Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy
April 23, 2018 - Metabolic differences may contribute to postpartum weight retention in black moms
April 23, 2018 - Time-Related Deployment Factors Predict Suicide Attempt Risk
April 23, 2018 - Are newborns ugly? Research says newborns rated ‘less cute’ than older babies
April 23, 2018 - Prenatal marijuana use linked to increased chance of low birth weights
April 23, 2018 - Researchers identify target gene in P. aeruginosa infection
April 23, 2018 - New studies related to causes of liver degradation and possible treatments
April 23, 2018 - Studies offer leads for new approaches to treat neurological problems
April 23, 2018 - Promising cell study may offer new opportunities for treating Parkinson’s disease
Can gene therapy be harnessed to fight the AIDS virus?

Can gene therapy be harnessed to fight the AIDS virus?

image_pdfDownload PDFimage_print
Can gene therapy be harnessed to fight the AIDS virus?
In this Jan. 26, 2018 photo, Matt Chappell, right, is checked by Dr. Christopher Schiessl during an appointment at a medical center in San Francisco. For more than a decade, the strongest AIDS drugs could not fully control Chappell’s HIV infection. Now his body does it by itself, thanks to the first gene editing experiments in people. (AP Photo/Jeff Chiu)

For more than a decade, the strongest AIDS drugs could not fully control Matt Chappell’s HIV infection. Now his body controls it by itself, and researchers are trying to perfect the gene editing that made this possible.

Scientists removed some of his blood cells, disabled a gene to help them resist HIV, and returned these “edited” cells to him in 2014. So far, it has given the San Francisco man the next best thing to a cure.

“I’ve been off medications for three and a half years,” he said. He even was able to keep the virus in check despite cancer treatments last year that taxed his immune system.

Chappell was lucky, though. Only a few of the 100 others in those experiments were able to stay off HIV drugs for a couple years; the rest still need medicines to keep HIV suppressed.

Now researchers think they can improve the treatment and are trying again to tackle HIV by doctoring DNA. New studies to test these tweaked approaches in people are getting underway.

“Gene therapy techniques have advanced greatly,” said Dr. Otto Yang of the UCLA AIDS Institute, one place working on this. “A lot of people are thinking it’s the right time to go back.”

They include Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which is funding some of the new studies. He doesn’t think the technique will become common because millions of people do well on existing treatments. But he says it could help those who can’t easily control the virus, and should be pursued because it holds potential for a cure.

Can gene therapy be harnessed to fight the AIDS virus?
In this Jan. 26, 2018 photo, Matt Chappell, left, talks with Dr. Christopher Schiessl during an appointment at a medical center in San Francisco. For more than a decade, the strongest AIDS drugs could not fully control Chappell’s HIV infection. Now his body does it by itself, thanks to the first gene editing experiments in people. (AP Photo/Jeff Chiu)

“They’re very bold, innovative techniques, mostly to try and cure people,” he said. “It’s worth trying because the science is there.”

ONE MAN’S CURE GAVE HOPE

Only one person is known to have been cured of HIV infection, a man who had a cell transplant a decade ago from a donor with natural immunity to the virus. The donor lacked a common gene that makes an entryway HIV uses to infect T cells, immune system soldiers in the blood.

The transplant gave the recipient that protection, but procedures like that are too risky and impractical for wide use. Scientists have been trying to find a way to create similar immunity by altering some of a patient’s own cells. They use a gene editing tool called zinc finger nucleases, which cut DNA at a precise spot to disable the HIV entryway gene.

The California company that makes the editing tool, Sangamo Therapeutics, sponsored the initial studies.

Can gene therapy be harnessed to fight the AIDS virus?
In this Jan. 26, 2018 photo, Matt Chappell, right, talks with Dr. Christopher Schiessl during an appointment at a medical center in San Francisco. For more than a decade, the strongest AIDS drugs could not fully control Chappell’s HIV infection. Now his body does it by itself, thanks to the first gene editing experiments in people. (AP Photo/Jeff Chiu)

“It worked, the T cells were edited,” said Sangamo’s president, Dr. Sandy Macrae. But it didn’t work quite well enough: The altered T cells were outnumbered by T cells that were not altered and could still be infected.

Now, Dr. John Zaia at City of Hope, a research center in Duarte, California, is trying the approach with a twist. He’s using blood stem cells—parent cells that produce many others. Once a stem cell is altered the benefit should multiply and last longer, Zaia said.

THE SILVER LINING

Though the initial gene editing experiments were disappointing, there was a silver lining. Patients in those studies had a big drop in the number of cells where HIV lurked in a dormant state—the so-called reservoir of silent disease.

At Case Western Reserve University in Cleveland, Dr. Rafick-Pierre Sekaly is trying to capitalize on that drop. His study will try the same gene editing—disabling the gene that makes the HIV entryway—while keeping patients on strong antiviral medicines for at least a year before discontinuing them.

Can gene therapy be harnessed to fight the AIDS virus?
In this Tuesday, Jan. 23, 2018 photo, James Riley, an HIV and gene therapy expert at the University of Pennsylvania, poses for a photograph in Philadelphia. Gene therapy has scored wins against some rare blood diseases and even a form of blindness. Now scientists are trying it for a much more common foe, HIV, the virus that causes AIDS. (AP Photo/Matt Rourke)

“As long as we’re not able to get rid of this reservoir, we’ll never be able to stop treatment,” he explained.

The hope is that the medicines plus the altered cells will knock down the virus and reduce the reservoir to a point where the body can control any residual disease by itself, as Chappell seems to be doing.

PROTECT AND ATTACK

University of Pennsylvania scientists are trying a two-part approach: Besides knocking out the gene for the HIV entryway, they’re adding a gene to help T cells recognize and kill HIV. This second part is called CAR-T therapy, a treatment approved last year for treating cancer.

The new study’s leader, scientist James Riley, is encouraged that some patients at Penn who were in the early studies kept HIV suppressed for nearly a year without drugs.

Can gene therapy be harnessed to fight the AIDS virus?
In this Tuesday, Jan. 23, 2018 photo, James Riley, an HIV and gene therapy expert at the University of Pennsylvania, speaks during an interview in Philadelphia. Gene therapy has scored wins against some rare blood diseases and even a form of blindness. Now scientists are trying it for a much more common foe, HIV, the virus that causes AIDS. (AP Photo/Matt Rourke)

“You’d never know they were sick” even though the virus could still be detected, Riley said. “At some point you’re going to have confidence that it’s not going to come back.”

Chappell’s doctor, Christopher Schiessl at One Medical, a health clinic in San Francisco, hopes that’s the case for Chappell. Although he’s doing well now, Chappell is showing signs that his immune system may be weakening, Schiessl said.

Chappell is optimistic, and believes gene therapy ultimately will provide a long-term solution.

“If we’re going to cure HIV,” he said, “this is how it’s going to happen.”


Explore further:
Gene therapy using CAR T-cells could provide long-term protection against HIV

Tagged with:

About author

Related Articles